Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > Delisting

<< Previous

Bullboard Posts

Next >>

Comment by Barewoodon Jul 10, 2018 9:41pm

144 Views

Post# 28297097

RE:RE:Delisting

NASDAQ's $1.00 minimum Bid share price must be held for 10 days straight. They have the "voted" reverse split as a bargaining chip which they intend to use at their hearing on the 13th. I don't see any problem with them getting an extension to the end of the Year.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"